Role of radiation therapy in the management of pancreatic cancer

被引:42
作者
Goodman, Karyn A. [1 ]
Hajj, Carla [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA
关键词
resectable pancreatic cancer; radiotherapy; locally advanced pancreatic cancer; INTENSITY-MODULATED RADIOTHERAPY; PHASE-II; UNRESECTABLE ADENOCARCINOMA; STEREOTACTIC RADIOSURGERY; INTRAOPERATIVE RADIATION; DUCTAL ADENOCARCINOMA; EXTERNAL BEAM; PREOPERATIVE CHEMORADIATION; CONFORMAL RADIOTHERAPY; ADJUVANT CHEMOTHERAPY;
D O I
10.1002/jso.23137
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Local failure remains a major issue for patients with both resectable and locally advanced pancreatic cancer. The role of radiation therapy in the management of this disease is less clear and represents an area of some controversy. The objective of this review is to present the rationale for radiation therapy in pancreatic cancer, as well as to discuss the potential limitations and caveats of the currently available studies. J. Surg. Oncol. 2013;107:8696. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:86 / 96
页数:11
相关论文
共 80 条
[1]   EXPERIENCE WITH FAST-NEUTRON THERAPY FOR UNRESECTABLE CARCINOMA OF THE PANCREAS [J].
ALABDULLA, ASM ;
HUSSEY, DH ;
OLSON, MH ;
WRIGHT, AE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1981, 7 (02) :165-172
[2]  
[Anonymous], J GASTROINTEST CANC
[3]  
[Anonymous], NIH PUBL
[4]  
[Anonymous], ANN ONCOL UNPUB
[5]  
[Anonymous], ANN SURG ONCOL
[6]  
Bai YR, 2003, WORLD J GASTROENTERO, V9, P2561
[7]   Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer [J].
Ben-Josef, E ;
Shields, AF ;
Vaishampayan, U ;
Vaitkevicius, V ;
El-Rayes, BF ;
McDermott, P ;
Burmeister, J ;
Bossenberger, T ;
Philip, PA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (02) :454-459
[8]   Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: A strategy for large-scale implementation for the treatment of carcinoma of the prostate [J].
Burman, C ;
Chui, CS ;
Kutcher, G ;
Leibel, S ;
Zelefsky, M ;
LoSasso, T ;
Spirou, S ;
Wu, QW ;
Yang, J ;
Stein, J ;
Mohan, R ;
Fuks, Z ;
Ling, CC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (04) :863-873
[9]   Stereotactic Radiotherapy for Unresectable Adenocarcinoma of the Pancreas [J].
Chang, Daniel T. ;
Schellenberg, Devin ;
Shen, John ;
Kim, Jeff ;
Goodman, Karyn A. ;
Fisher, George A. ;
Ford, James M. ;
Desser, Terry ;
Quon, Andrew ;
Koong, Albert C. .
CANCER, 2009, 115 (03) :665-672
[10]   Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer.: Definitive results of the 2000-01 FFCD/SFRO study [J].
Chauffert, B. ;
Mornex, F. ;
Bonnetain, F. ;
Rougier, P. ;
Mariette, C. ;
Bouche, O. ;
Bosset, J. F. ;
Aparicio, T. ;
Mineur, L. ;
Azzedine, A. ;
Hammel, P. ;
Butel, J. ;
Stremsdoerfer, N. ;
Maingon, P. ;
Bedenne, L. .
ANNALS OF ONCOLOGY, 2008, 19 (09) :1592-1599